Benazepril/hctz 20/12.5mg Tablets

Manufacturer GLENMARK PHARMACEUTICALS Active Ingredient Benazepril and Hydrochlorothiazide(ben AY ze pril & hye droe klor oh THYE a zide) Pronunciation ben AY ze pril & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Angiotensin-converting enzyme (ACE) inhibitor and Thiazide diuretic combination
🤰
Pregnancy Category
Not available
✅
FDA Approved
Mar 1995
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a combination of two drugs: an ACE inhibitor (benazepril) and a diuretic (hydrochlorothiazide). It works by relaxing blood vessels and helping your body get rid of excess salt and water, which lowers your blood pressure. It's used to treat high blood pressure (hypertension).
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided to you and follow the instructions closely. Take your medication at the same time every day to establish a routine. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

It's essential to note that this medication may increase your urine production, which can disrupt your sleep patterns if taken too close to bedtime. To minimize this effect, try to take your medication earlier in the day. Additionally, drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, away from direct light and heat sources. Keep it in a dry place, avoiding storage in a bathroom. Protect your medication from excessive heat and keep it out of reach of children and pets. Store all your medications in a safe and secure location.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily, with or without food.
  • Do not stop taking this medication without consulting your doctor, even if you feel well.
  • Limit alcohol intake, as it can further lower blood pressure.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor.
  • Maintain a healthy diet low in sodium and saturated fats.
  • Engage in regular physical activity as advised by your doctor.
  • Monitor your blood pressure regularly at home if recommended by your doctor.
  • Stay well-hydrated, especially in hot weather or during exercise, but avoid excessive fluid intake unless advised.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: One tablet (Benazepril/HCTZ 20/12.5 mg) orally once daily
Dose Range: 5 - 40 mg

Condition-Specific Dosing:

initial_hypertension: Initial dose is typically Benazepril/HCTZ 10/12.5 mg or 20/12.5 mg once daily. The 20/12.5 mg strength is often used when patients are not adequately controlled on monotherapy or require higher initial doses.
maintenance_hypertension: Dosage should be individualized. Max recommended daily dose of benazepril is 40 mg and HCTZ is 50 mg. The 20/12.5 mg strength is a common maintenance dose.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No initial dosage adjustment needed for CrCl >30 mL/min.
Moderate: For CrCl ≤30 mL/min, the use of combination products is generally not recommended. Consider individual components. If used, start with lower doses of benazepril (e.g., 5 mg) and HCTZ (e.g., 6.25 mg) and titrate carefully.
Severe: Contraindicated in anuria or severe renal impairment (CrCl <30 mL/min) due to the hydrochlorothiazide component.
Dialysis: Benazeprilat is dialyzable to some extent, but HCTZ is not effectively removed by dialysis. Contraindicated in anuria. Use with extreme caution, if at all, in patients on dialysis.

Hepatic Impairment:

Mild: Use with caution. Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, as minor alterations of fluid and electrolyte balance may precipitate hepatic coma.
Moderate: Use with caution. Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, as minor alterations of fluid and electrolyte balance may precipitate hepatic coma.
Severe: Contraindicated in severe hepatic impairment due to the hydrochlorothiazide component, as it may precipitate hepatic coma.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Benazepril is an angiotensin-converting enzyme (ACE) inhibitor. It prevents the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, leading to decreased systemic vascular resistance, reduced aldosterone secretion (which decreases sodium and water reabsorption), and increased bradykinin levels (leading to vasodilation). Hydrochlorothiazide is a thiazide diuretic. It inhibits sodium reabsorption in the distal convoluted tubule, leading to increased excretion of sodium, chloride, and water. It also increases potassium and magnesium excretion and decreases calcium excretion. The combination provides additive antihypertensive effects and helps mitigate some of the electrolyte imbalances (e.g., hypokalemia) that can occur with diuretic monotherapy.
📊

Pharmacokinetics

Absorption:

Bioavailability: Benazepril: ~37% (as benazeprilat); HCTZ: ~65-75%
Tmax: Benazeprilat: 1-2 hours; HCTZ: 1-2.5 hours
FoodEffect: Food does not significantly affect the absorption of benazepril or hydrochlorothiazide.

Distribution:

Vd: Benazeprilat: ~9 L/kg; HCTZ: ~0.8 L/kg
ProteinBinding: Benazeprilat: ~95%; HCTZ: ~40-68%
CnssPenetration: Limited

Elimination:

HalfLife: Benazeprilat: 10-11 hours (effective half-life); HCTZ: 5.6-14.8 hours
Clearance: Benazeprilat: Primarily renal; HCTZ: Primarily renal
ExcretionRoute: Benazeprilat: Urine (primarily); HCTZ: Urine (primarily)
Unchanged: Benazepril: <1% (as benazepril); HCTZ: >95%
âąī¸

Pharmacodynamics

OnsetOfAction: Benazepril: ~1 hour; HCTZ: ~2 hours
PeakEffect: Benazepril: 2-4 hours; HCTZ: 4-6 hours
DurationOfAction: Benazepril: 24 hours; HCTZ: 6-12 hours (antihypertensive effect can last up to 24 hours)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

FETAL TOXICITY: When pregnancy is detected, discontinue Benazepril/Hydrochlorothiazide as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high blood sugar, such as:
+ Confusion
+ Drowsiness
+ Increased thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of fluid and electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Abnormal heartbeat
+ Severe dizziness or fainting
+ Increased thirst
+ Seizures
+ Fatigue or weakness
+ Decreased appetite
+ Changes in urine output
+ Dry mouth
+ Dry eyes
+ Severe nausea or vomiting
Persistent cough
Stomach pain
Eye problems, such as changes in vision or eye pain, which can lead to permanent vision loss if left untreated. These symptoms usually occur within hours to weeks of starting the medication.
Signs of liver problems, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Nausea or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes

Other Important Warnings

This medication can increase the risk of certain types of skin cancer. Protect your skin from the sun and follow your doctor's instructions for skin checks. If you notice any changes in the color or size of a mole, or any new or changing skin lump or growth, contact your doctor immediately.
Liver problems have been reported with similar medications, and in some cases, have been fatal.

Common Side Effects

Not everyone experiences side effects, and many people have only minor symptoms. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Dizziness
Fatigue
Weakness
Cough
* Headache

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Swelling of the face, lips, tongue, or throat (angioedema) - seek emergency medical attention immediately.
  • Difficulty breathing or swallowing - seek emergency medical attention immediately.
  • Severe dizziness or fainting.
  • Persistent dry cough.
  • Signs of electrolyte imbalance: unusual tiredness, muscle weakness, muscle cramps, irregular heartbeat, severe nausea/vomiting.
  • Signs of kidney problems: decreased urination, swelling in ankles/feet.
  • Yellowing of skin or eyes (jaundice).
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions and situations to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction and its symptoms.
A known sulfa allergy.
A history of angioedema, a severe and potentially life-threatening reaction characterized by symptoms such as swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing, swallowing problems, or unusual hoarseness.
High calcium levels in your blood.
Urinary retention, which means you are unable to pass urine.
Current or planned use of the following medications:
+ Azilsartan
+ Candesartan
+ Eprosartan
+ Fimasartan
+ Irbesartan
+ Losartan
+ Olmesartan
+ Telmisartan
+ Valsartan
Use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.
Use of dofetilide.
Recent use (within the last 36 hours) of a medication containing sacubitril.
Breast-feeding or plans to breast-feed.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health issues. Never start, stop, or adjust the dose of any medication without consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and be cautious when climbing stairs.

Monitoring Your Condition
If you have diabetes (high blood sugar), closely monitor your blood sugar levels. Check your blood pressure as directed by your healthcare provider. Additionally, have your blood work and other laboratory tests done as scheduled by your doctor.

Interference with Lab Tests
This medication may affect certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this medication.

Dietary Considerations
If you are on a low-salt or salt-free diet, consult with your doctor. Also, discuss with your doctor if you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product.

Over-the-Counter (OTC) Products
Before using OTC products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids, consult with your doctor.

Interactions with Other Medications
If you take cholestyramine or colestipol, consult with your pharmacist about how to take them with this medication. Before using alcohol, marijuana or other forms of cannabis, or prescription or OTC medications that may slow your actions, discuss with your doctor.

Potential Side Effects
Be aware of the following potential side effects:
- Gout attacks: Monitor for symptoms
- Lupus: This medication can activate or worsen lupus. Report any new or worsening symptoms to your doctor immediately
- High cholesterol and triglyceride levels: If you have high cholesterol or triglycerides, discuss with your doctor
- Low white blood cell counts: This can increase the risk of infection, particularly in people with kidney problems. Seek medical attention if you experience symptoms like fever, chills, or sore throat

Heat and Fluid Loss
In hot weather or during physical activity, drink plenty of fluids to prevent dehydration. Inform your doctor if you experience excessive sweating, fluid loss, vomiting, or diarrhea, as these can lead to low blood pressure.

Angioedema
A severe and potentially life-threatening reaction called angioedema can occur. The risk may be higher in Black patients.

Special Considerations for Older Adults
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (low blood pressure)
  • Dizziness
  • Lightheadedness
  • Fainting
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Electrolyte imbalances (e.g., hypokalemia, hyponatremia)
  • Dehydration
  • Renal failure

What to Do:

Call 911 or your local poison control center (1-800-222-1222 in the US) immediately. Treatment is supportive and symptomatic, including intravenous fluids for hypotension and correction of electrolyte imbalances. Hemodialysis may be considered for severe cases, though HCTZ is not effectively dialyzable.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
  • Sacubitril/valsartan (Entresto) - concomitant use or within 36 hours of switching
  • Angiotensin Receptor Blockers (ARBs) - in patients with diabetes or renal impairment (dual blockade)
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride) - increased risk of hyperkalemia
  • Potassium supplements - increased risk of hyperkalemia
  • Lithium - increased serum lithium levels and toxicity
  • NSAIDs (including COX-2 inhibitors) - may reduce antihypertensive effect, increase risk of renal impairment (especially in elderly, volume-depleted, or renally impaired patients)
  • Other antihypertensives - additive hypotensive effects
  • Insulin and oral antidiabetic agents - HCTZ may decrease glucose tolerance, requiring adjustment of antidiabetic medication
  • Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia
  • Digoxin - hypokalemia/hypomagnesemia induced by HCTZ can increase digoxin toxicity
  • Allopurinol - increased risk of hypersensitivity reactions to allopurinol
  • Colestyramine and colestipol resins - impaired absorption of HCTZ
🟡

Moderate Interactions

  • Barbiturates, narcotics, alcohol - may potentiate orthostatic hypotension
  • Pressor amines (e.g., norepinephrine) - possible decreased response to pressor amines
  • Skeletal muscle relaxants, non-depolarizing (e.g., tubocurarine) - possible increased responsiveness to the muscle relaxant
  • Calcium salts - increased serum calcium levels due to decreased excretion by HCTZ
  • Immunosuppressants (e.g., cyclosporine) - increased risk of hyperuricemia and gout-type complications with HCTZ
  • Trimethoprim - increased risk of hyperkalemia
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and assess efficacy.

Timing: Prior to initiation

Serum Creatinine (Cr) and Blood Urea Nitrogen (BUN)

Rationale: To assess renal function, as both drugs are renally cleared and can affect kidney function.

Timing: Prior to initiation

Serum Electrolytes (Sodium, Potassium, Magnesium, Calcium)

Rationale: To establish baseline and identify pre-existing imbalances; HCTZ can cause hypokalemia, hyponatremia, hypomagnesemia, and hypercalcemia; Benazepril can cause hyperkalemia.

Timing: Prior to initiation

Uric Acid

Rationale: HCTZ can increase serum uric acid levels.

Timing: Prior to initiation

Fasting Blood Glucose

Rationale: HCTZ can impair glucose tolerance.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, e.g., weekly after initiation/dose change, then monthly/quarterly once stable

Target: <130/80 mmHg (individualized based on guidelines and patient comorbidities)

Action Threshold: Persistent elevation above target, or symptomatic hypotension

Serum Creatinine (Cr) and BUN

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months, or more frequently in patients with pre-existing renal impairment or on concomitant nephrotoxic drugs.

Target: Stable or within acceptable limits for patient's baseline

Action Threshold: Increase in Cr >30% from baseline, or significant decline in GFR; consider dose reduction or discontinuation.

Serum Electrolytes (Sodium, Potassium, Magnesium, Calcium)

Frequency: 1-2 weeks after initiation/dose change, then every 3-6 months, or more frequently in patients with pre-existing imbalances or on concomitant interacting drugs.

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L; Magnesium: 1.7-2.2 mg/dL; Calcium: 8.5-10.2 mg/dL

Action Threshold: Significant hypokalemia (<3.0 mEq/L), hyperkalemia (>5.5 mEq/L), hyponatremia (<130 mEq/L), or symptomatic electrolyte disturbances.

Uric Acid

Frequency: Annually, or if symptoms of gout develop.

Target: Within normal limits

Action Threshold: Significant elevation or symptomatic gout.

Fasting Blood Glucose

Frequency: Annually, or more frequently in diabetic patients.

Target: Within target for diabetic/non-diabetic patients

Action Threshold: Significant hyperglycemia.

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Fatigue
  • Dry cough (persistent, non-productive)
  • Swelling of face, lips, tongue, or throat (angioedema)
  • Difficulty breathing
  • Muscle cramps or weakness (electrolyte imbalance)
  • Unusual thirst
  • Nausea/vomiting
  • Signs of infection (fever, sore throat - rare, but possible neutropenia)

Special Patient Groups

🤰

Pregnancy

CONTRAINDICATED. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Discontinue as soon as pregnancy is detected.

Trimester-Specific Risks:

First Trimester: Limited human data, but potential for fetal harm cannot be excluded. Animal studies suggest risk. Due to the known risks in later trimesters, discontinuation is recommended as soon as pregnancy is detected.
Second Trimester: Significant risk of fetal injury and death, including fetal hypotension, anuria, oligohydramnios, skull hypoplasia, lung hypoplasia, skeletal deformations, and death.
Third Trimester: Significant risk of fetal injury and death, including fetal hypotension, anuria, oligohydramnios, skull hypoplasia, lung hypoplasia, skeletal deformations, and death. Neonatal complications may include renal failure, hypotension, and hyperkalemia.
🤱

Lactation

Both benazepril and hydrochlorothiazide are excreted into human milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., hypotension, hyperkalemia, and effects on renal function from benazepril; and potential for hypokalemia, jaundice, and growth inhibition from HCTZ), breastfeeding is generally not recommended during treatment.

Infant Risk: Moderate to High (L3 - L4). Potential for hypotension, hyperkalemia, renal dysfunction, and electrolyte disturbances in the infant. HCTZ may also suppress lactation.
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

Use with caution. Elderly patients may be more sensitive to the hypotensive and electrolyte effects (e.g., hypokalemia, hyponatremia) and may have age-related decline in renal function, requiring careful dose titration and monitoring. Start with lower doses and monitor closely.

Clinical Information

💎

Clinical Pearls

  • This combination is effective for patients whose blood pressure is not adequately controlled with monotherapy or who experience diuretic-induced hypokalemia with HCTZ alone.
  • The dry cough is a common side effect of ACE inhibitors and is not dose-dependent. If bothersome, switching to an ARB/diuretic combination may be considered.
  • Angioedema is a rare but life-threatening side effect of ACE inhibitors. Patients should be educated on its symptoms and instructed to seek immediate medical attention if it occurs.
  • Monitor for orthostatic hypotension, especially at initiation, with dose increases, or in volume-depleted patients.
  • Advise patients to avoid sudden changes in position to minimize dizziness.
  • Patients should be advised to report any signs of infection (e.g., fever, sore throat) due to the rare risk of neutropenia with ACE inhibitors.
  • Thiazide diuretics can worsen gout and diabetes control; monitor uric acid and blood glucose levels accordingly.
🔄

Alternative Therapies

  • Other classes of antihypertensives (e.g., Calcium Channel Blockers, Beta-blockers, Alpha-blockers, direct vasodilators)
  • ACE inhibitor monotherapy (e.g., Benazepril)
  • Thiazide diuretic monotherapy (e.g., Hydrochlorothiazide)
  • Angiotensin Receptor Blocker (ARB) monotherapy
  • Other diuretic classes (e.g., loop diuretics, potassium-sparing diuretics)
💰

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.